The global non-vascular stents market is on track for substantial expansion, with projections indicating a market value of USD 1,408.7 million in 2025, soaring to USD 2,338.8 million by 2035.

The growing existence of cardiovascular illnesses worldwide is a prominent factor driving the vascular stent market. The market involves various stent types such as drug-eluting stents (DES), ...

The contribution of vascular proliferation to the pathophysiology of in-stent restenosis, transplant vasculopathy and vein bypass graft failure is particularly important. Thus, an emerging ...

Peripheral Vascular Disease (PVD) is a common complication for those with diabetes, significantly impacting blood flow and increasing the risk of severe complications like infections, ulcers, and in ...

Heart and vascular care at OhioHealth Mansfield Hospital received a $5 million upgrade this year as part of a $14.9 million ...

TeamBest Global Companies logo - 2025 CRT Lifetime Achievement Award Brachytherapy Research & Educational Foundation (BREF) ...

Teleflex Incorporated (NYSE: TFX) has announced its agreement to acquire BIOTRONIK’s Vascular Intervention business in a transaction valued at approximately €760 million. With this strategic ...

As noted in the press release, the acquired Biotronik Vascular Intervention business includes the following: For coronary interventions, the Pantera Lux drug-coated balloon catheter; the PK Papyrus ...

We value keeping the Device Guide up to date.